Norway: Norwegian Medicines Agency [clinicaltrials_resource:bbd0269ded44e91f74c033ef2ce7352e]
Improving Diabetic Foot Ulcers With Atorvastatin [clinicaltrials:NCT00134550]Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy [clinicaltrials:NCT00160186]Differentiation Induction in Acute Myelogenous Leukemia [clinicaltrials:NCT00175812]Hemodynamic Measurements in Women With Serious Preeclampsia [clinicaltrials:NCT00199810]Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC [clinicaltrials:NCT00201435]Hepatitis C Treatment of Inmates [clinicaltrials:NCT00209898]clinicaltrials:NCT00218855Weight Loss and Changes in Cardiovascular Risk Markers With a Low Glycemic Diet Compared With a Standard Diet [clinicaltrials:NCT00230919]Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes [clinicaltrials:NCT00284232]RATe Control in Atrial Fibrillation [clinicaltrials:NCT00313157]Observational Study of the Remodelling Process Following Myocardial Infarct [clinicaltrials:NCT00338156]Vitamin D Supplementation to Patients With Type 2 Diabetes [clinicaltrials:NCT00400491]Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089) [clinicaltrials:NCT00413764]Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [clinicaltrials:NCT00419146]Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients (19.4.309)(P05934)(COMPLETED) [clinicaltrials:NCT00420680]Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation. [clinicaltrials:NCT00423384]Vorinostat and Palliative Radiotherapy [clinicaltrials:NCT00455351]clinicaltrials:NCT00455416clinicaltrials:NCT00511342Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction [clinicaltrials:NCT00521157]Interaction Between Rimonabant and Cyclosporine and Tacrolimus [clinicaltrials:NCT00525681]Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00533728]Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy [clinicaltrials:NCT00664976]clinicaltrials:NCT00685672Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers [clinicaltrials:NCT00730054]Sitagliptin in Renal Transplant Recipients [clinicaltrials:NCT00740363]Idiopathic Reactive Hypoglycaemia and Treatment With Fructo-Oligosaccharide [clinicaltrials:NCT00802971]clinicaltrials:NCT00826462Drug Intervention in Chronic Fatigue Syndrome [clinicaltrials:NCT00848692]Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction [clinicaltrials:NCT00862888]Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults [clinicaltrials:NCT00868218]Vitamin D, Blood Pressure, Lipids, Infection and Depression [clinicaltrials:NCT00960232]Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00961844]clinicaltrials:NCT00977769clinicaltrials:NCT00992797Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine [clinicaltrials:NCT00995332]clinicaltrials:NCT01003288Study of MOC31-PE in Antigen Positive Carcinomas [clinicaltrials:NCT01061645]A Phase IV, Prospective, Observational, Open Label, Single Centre Cohort Trial to be Conducted in Norway During One Year to Assess the Cumulative Pregnancy Rate in a New Series of In-vitro Fertilization (IVF) Treatment Cycles Following Three or More Previous IVF Treatment Cycles Without Live Birth [clinicaltrials:NCT01071148]clinicaltrials:NCT01092806
oversight [clinicaltrials_vocabulary:oversight]
Norway: Norwegian Medicines Agency [clinicaltrials_resource:bbd0269ded44e91f74c033ef2ce7352e]
Bio2RDF identifier
bbd0269ded44e91f74c033ef2ce7352e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bbd0269ded44e91f74c033ef2ce7352e
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:bbd0269ded44e91f74c033ef2ce7352e
title
Norway: Norwegian Medicines Agency
@en
type
label
Norway: Norwegian Medicines Ag ...... 0269ded44e91f74c033ef2ce7352e]
@en